NasdaqGS - Nasdaq Real Time Price USD
Innate Pharma S.A. (IPHA)
As of 12:01 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2019) | Next Qtr. (Dec 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2019) | Next Qtr. (Dec 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 4 |
| Avg. Estimate | -- | 23.94M | 100.71M | 85.64M |
| Low Estimate | 30.17M | 25.01M | 99M | 76.1M |
| High Estimate | 30.17M | 25.01M | 120.24M | 145.44M |
| Year Ago Sales | -- | -- | -- | 100.71M |
| Sales Growth (year/est) | -- | -- | -- | -15.00% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2019) | Next Qtr. (Dec 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0.04 | -0.18 | 0.06 | -0.17 |
| 30 Days Ago | 0.04 | -0.18 | 0.06 | -0.17 |
| 60 Days Ago | 0.04 | -0.18 | 0.06 | -0.17 |
| 90 Days Ago | 0.04 | -0.18 | 0.06 | -0.17 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2019) | Next Qtr. (Dec 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IPHA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 4.40% |
| Next Qtr. | -- | -- | -- | 7.80% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.89% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2023 |
Related Tickers
PRTC PureTech Health plc
20.38
-0.12%
AVBP ArriVent BioPharma, Inc.
28.91
+1.74%
AURX Nuo Therapeutics, Inc.
0.6000
+12.99%
INZY Inozyme Pharma, Inc.
5.35
-0.37%
APLMW Apollomics, Inc.
0.0122
+0.83%
CLAZF Claritas Pharmaceuticals, Inc.
0.0001
0.00%
GNFT Genfit S.A.
6.29
+5.18%
ISCO International Stem Cell Corporation
0.0700
0.00%
STAB Statera Biopharma, Inc.
0.0001
0.00%
METX.CN METheraHld
4.9000
0.00%